PLATANIA, CHIARA BIANCA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.762
EU - Europa 1.773
AS - Asia 1.472
AF - Africa 295
SA - Sud America 244
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 6.553
Nazione #
US - Stati Uniti d'America 2.682
SG - Singapore 760
RU - Federazione Russa 633
IT - Italia 576
CN - Cina 448
BR - Brasile 213
IE - Irlanda 201
CI - Costa d'Avorio 182
UA - Ucraina 87
DE - Germania 74
VN - Vietnam 71
SN - Senegal 70
KR - Corea 64
CA - Canada 51
GB - Regno Unito 46
SE - Svezia 32
IN - India 31
FI - Finlandia 25
PL - Polonia 25
JP - Giappone 22
MX - Messico 20
AR - Argentina 16
NL - Olanda 14
HK - Hong Kong 13
ZA - Sudafrica 13
BD - Bangladesh 11
ES - Italia 11
FR - Francia 11
BE - Belgio 8
NG - Nigeria 8
TR - Turchia 8
BJ - Benin 7
IQ - Iraq 7
CH - Svizzera 6
ID - Indonesia 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
EC - Ecuador 5
KE - Kenya 5
MA - Marocco 5
CZ - Repubblica Ceca 4
EU - Europa 4
TN - Tunisia 4
UZ - Uzbekistan 4
AU - Australia 3
CO - Colombia 3
GR - Grecia 3
NP - Nepal 3
PK - Pakistan 3
PY - Paraguay 3
AL - Albania 2
AZ - Azerbaigian 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
LK - Sri Lanka 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
YE - Yemen 1
Totale 6.553
Città #
Singapore 463
Santa Clara 438
Dallas 421
Chandler 321
Moscow 270
Dublin 201
Abidjan 182
Catania 179
Chicago 162
Ashburn 127
Hefei 120
Jacksonville 94
Houston 90
Boardman 82
Beijing 73
Dakar 70
Seoul 61
Los Angeles 56
Cambridge 48
Lawrence 47
Andover 43
Civitanova Marche 35
New York 32
Ho Chi Minh City 28
Toronto 27
Wilmington 27
Des Moines 24
Nanjing 23
Rome 23
São Paulo 22
Bremen 21
Buffalo 20
Seattle 19
The Dalles 18
Tokyo 18
Warsaw 18
Council Bluffs 17
Hanoi 17
Aci Catena 16
Columbus 16
Falls Church 16
Messina 16
Orem 15
Palermo 15
Milan 13
Rio de Janeiro 13
Lappeenranta 12
Munich 12
Stockholm 12
Brooklyn 11
Phoenix 11
Redwood City 11
Boydton 10
Changsha 10
Dong Ket 10
Hebei 10
Hong Kong 10
Ottawa 10
Saint Petersburg 10
Shenyang 10
Belo Horizonte 9
Manchester 9
Mumbai 9
Naples 9
San Mateo 9
Abuja 8
Grafing 8
Johannesburg 8
Mexico City 8
Montreal 8
Redmond 8
Redondo Beach 8
Cotonou 7
Jiaxing 7
Nanchang 7
San Gregorio di Catania 7
Atlanta 6
Chennai 6
Dearborn 6
Denver 6
Guangzhou 6
London 6
Pozzallo 6
Rosolini 6
Shanghai 6
Brasília 5
Bronte 5
Brussels 5
Cagliari 5
Curitiba 5
Hyderabad 5
Manaus 5
Nairobi 5
San Francisco 5
Turku 5
Washington 5
Ankara 4
Baranzate 4
Boston 4
Busto Garolfo 4
Totale 4.460
Nome #
Current drug treatments targeting dopamine D3 receptor 221
Antioxidant and osmoprotecting activity of taurine in dry eye models 175
Caffeine Protects Against Retinal Inflammation 148
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 148
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 144
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 142
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 142
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 137
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 134
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 132
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 126
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 125
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 122
Controversies in Glaucoma: Current Medical Treatment and Drug Development 121
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 120
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 118
Drug delivery of synthetic antisense “Bioconjugates” for anticancer therapy DNA. 117
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 115
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 114
Novel therapeutics in glaucoma management 110
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 110
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 110
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 107
Retinal protection and distribution of curcumin in vitro and in vivo 107
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 105
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 105
P2X7 receptor antagonism: implications in diabetic retinopathy 105
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 104
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 104
Drug Delivery of Synthetic Antisense-DNA “bioconjugates” for Anticancer Therapy 103
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 103
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 103
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 101
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 99
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 99
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 97
Do extracellular RNAs provide insight into uveal melanoma biology? 97
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 96
Ocular pharmacological profile of hydrocortisone in dry eye disease 96
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 95
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 95
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 91
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 91
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 90
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 89
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) 88
Integrating network pharmacology: The next-generation approach in ocular drug discovery 86
DRUG DELIVERY OF SYNTHETIC ANTISENSE-DNA "BIOCONJUGATES" FOR ANTICANCER THERAPY 84
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease 81
In-Silico Characterization of von Willebrand Factor Bound to FVIII 80
Characterization of protein-protein interfaces through a protein contact network approach 79
Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose 76
MicroRNA target prediction in glaucoma 73
Novel heme oxygenase-1 (Ho-1) inducers based on dimethyl fumarate structure 73
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors 73
Ocular allergy 72
Molecular basis of alcohol intake: role of D3 dopaminergic receptor 71
Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study 65
Implications of dopamine D3 receptor for glaucoma: in-silico and in-vivo studies 62
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach 62
The P2X7 receptor as a new pharmacological target for retinal diseases 60
Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs 55
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. 54
Erratum: Homology modeling of dopamine D2 and D3 receptors: Molecular dynamics refinement and docking evaluation (PLoS ONE (2013) 8:1 DOI: 10.1371/annotation/bd61cc74-2a2c-4433-a78d-84fa2310e919) 51
Ocular Allergies 51
α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells 48
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 27
Totale 6.684
Categoria #
all - tutte 21.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 13 34 5 19 15 27 20
2021/2022385 31 45 10 6 50 18 64 21 32 6 19 83
2022/2023927 61 66 17 109 121 120 16 170 173 16 31 27
2023/2024403 32 43 18 21 31 115 7 30 1 3 57 45
2024/20251.769 42 254 75 128 373 242 100 56 129 106 152 112
2025/20262.506 243 184 604 251 550 674 0 0 0 0 0 0
Totale 6.684